Navigation Links
Insulin Crystals Holds Promise In Diabetes research

A novel method to aid the formation of insulin crystals in the pancreas is a major discovery effected by a University of Houston professor and his student, which holds promise in the field of diabetes research and diagnosis. //

Peter Vekilov, associate professor of chemical engineering, and Dimitra Georgiou, a recent doctoral graduate in chemical engineering, both in UH's Cullen College of Engineering, have been solely responsible for this finding. Since insufficient insulin production in the pancreas is one of the primary causes of adult-onset diabetes, Vekilov and Georgiou are studying the process of how insulin is produced in the first place. Understanding how the body creates this hormone will make it easier for researchers to discover why some individuals do not produce enough insulin and thus develop diabetes, Vekilov said. Specifically, the two have focused on the creation of insulin crystals, the form in which insulin is stored in the pancreas before it is released in the bloodstream.

Proinsulin, a molecular precursor to insulin itself, is the reason for these crystals. After an insulin molecule is produced from proinsulin, it attaches to an insulin crystal only in special locations where other insulin molecules have formed right angles, called kinks. Using atomic-force microscopy, they discovered a new mechanism by which insulin molecules attach themselves to crystals to form these kinks. They found that groups of insulin blocks create large protrusions, dubbed "mounds" by Vekilov and Georgiou. The very nature of these mounds results in the creation of multiple kinks – far more, in fact, than other methods of kink formation.

By providing so many spaces where insulin molecules can attach to an insulin crystal, these mounds allow for the rapid growth of that crystal and only form when there is a surplus of insulin that allows for rapid crystal growth. Since no mounds appear when there is a lack of insulin and insulin crystals b oth grow and dissolve at kinks, mounds are important sources of a crystal's net growth.

"Typically in nature, fast growth also results in fast dissolution," Vekilov said. "But this process cheats physics because when there isn't a lot of insulin, mounds don't form. It's an asymmetric mechanism that has no balance."

While this discovery will play a significant role in gaining a better understanding of diabetes, it also is an historic find in the area of crystal formation and use, as only the third mechanism of crystal formation ever discovered. Before this finding, there were only two known ways that crystals grew – the first was proposed in 1876 and the second in 1968. Though the first and second discoveries, proposed by prominent American scientist and founder of modern thermodynamics J.W. Gibbs and by Russian scientist V.V. Voronkov, respectively, only recently demonstrated their applicability to real systems.Vekilov and Georgiou have already experimentally proved this latest mechanism in the work.

"It is possible that crystals composed of materials other than insulin also grow in this manner," Vekilov said. "If so, this discovery could significantly impact any number of fields that deal with crystals. It can help us understand all processes of crystal formation, including semiconductor and optical materials, geological crystallization, ice formation and the physiological and pathological crystallization of proteins and small molecules."

source:Eureka Alet

Related medicine news :

1. Link between birth weight and Insulin Resistance
2. Easier Methods Required to Screen Insulin Resistance
3. Easier Methods Required to Screen Insulin Resistance
4. Insulin Resistance Linked To Difference In Gender
5. Adopting Easier Methods To Screen Insulin Resistance
6. Another Alternative For Diabetics On Insulin
7. Understanding Insulin Resistance
8. Caffeine Intake May reduce Insulin Sensitivity
9. Junk Food Causes High Level Of Insulin Resistance In Children
10. Increasing Insulin Response In Type 2 Diabetics With New Protein Mixture
11. Elevated Insulin Levels To Influence Levels Of Inflammatory Markers
Post Your Comments:

(Date:11/27/2015)... ... 27, 2015 , ... Avid collector, Andrew Hawley from Vintage Rock Posters, announces ... This is one of Joplin's most famous and beautiful concert posters. The concert was ... in Ann Arbor. The According to Hawley, "It is hard to believe that Joplin's ...
(Date:11/26/2015)... MI (PRWEB) , ... November 26, 2015 , ... ... for substance abuse located in central Michigan, have come together on Thanksgiving Day ... specially produced video, available for viewing on the Serenity Point YouTube channel, patients ...
(Date:11/26/2015)... Toronto, ON and Cambridge, ON (PRWEB) , ... ... ... announced today the availability of a real-time eReferral system for diagnostic imaging in ... CTs, ultrasounds, X-rays, mammography, BMD and Nuclear Medicine tests directly from their electronic ...
(Date:11/26/2015)... ... ... The Catalent Applied Drug Delivery Institute today announced a ... selection in early phase drug development. The first of these is to be ... UK’s emerging life sciences companies, corporate partners, and investors, at Milton Park, Oxford, ...
(Date:11/26/2015)... San Antonio, TX (PRWEB) , ... November 26, 2015 , ... ... accomplishment! On November 19, 2015, our surgeons performed their 6,000th free flap breast ... Ledoux , “We wake up every day excited to rebuild lives and it’s an ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... of the "Radioimmunoassay Market by Type ... Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application ... Forecast to 2020" report to their ... announced the addition of the "Radioimmunoassay ...
(Date:11/25/2015)... , Nov. 25, 2015 ... addition of the "Global Brain Monitoring ... offering. --> ) has ... Brain Monitoring Devices Market 2015-2019" report ... and Markets ( ) has announced ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
Breaking Medicine Technology: